Phase I trial of intraperitoneal administration of an oncolytic measles virus strain engineered to express carcinoembryonic antigen for recurrent ovarian cancer.
Galanis, Evanthia
Phase I trial of intraperitoneal administration of an oncolytic measles virus strain engineered to express carcinoembryonic antigen for recurrent ovarian cancer. [electronic resource] - Cancer research Feb 2010 - 875-82 p. digital
Publication Type: Clinical Trial, Phase I; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
1538-7445
10.1158/0008-5472.CAN-09-2762 doi
Abdominal Pain--etiology
Adult
Aged
Aged, 80 and over
Animals
Carcinoembryonic Antigen--genetics
Chlorocebus aethiops
Fatigue--etiology
Female
Fever--etiology
Humans
Injections, Intraperitoneal
Measles virus--genetics
Middle Aged
Neoplasm Recurrence, Local
Oncolytic Virotherapy--adverse effects
Oncolytic Viruses--genetics
Ovarian Neoplasms--pathology
Recombinant Fusion Proteins--administration & dosage
Treatment Outcome
Vero Cells
Phase I trial of intraperitoneal administration of an oncolytic measles virus strain engineered to express carcinoembryonic antigen for recurrent ovarian cancer. [electronic resource] - Cancer research Feb 2010 - 875-82 p. digital
Publication Type: Clinical Trial, Phase I; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
1538-7445
10.1158/0008-5472.CAN-09-2762 doi
Abdominal Pain--etiology
Adult
Aged
Aged, 80 and over
Animals
Carcinoembryonic Antigen--genetics
Chlorocebus aethiops
Fatigue--etiology
Female
Fever--etiology
Humans
Injections, Intraperitoneal
Measles virus--genetics
Middle Aged
Neoplasm Recurrence, Local
Oncolytic Virotherapy--adverse effects
Oncolytic Viruses--genetics
Ovarian Neoplasms--pathology
Recombinant Fusion Proteins--administration & dosage
Treatment Outcome
Vero Cells